Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06669585 · ClinicalTrials.gov registry record
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 3
A clinical trial of Cannabis and Memory, sponsored by L. Cinnamon Bidwell.
- Recruiting
- Registry status
- 64
- Enrollment target
- 1
- Study location
NCT06669585: Recruiting study of Cannabis and Memory, sponsored by L. Cinnamon Bidwell.
NCT06669585 is a study of Cannabis and Memory that is actively recruiting participants, run by L. Cinnamon Bidwell. The registered enrollment target is 64 participants, below the 108-participant average among 24 other Cannabis trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06669585, a study of Cannabis and Memory, is actively recruiting participants, sponsored by L. Cinnamon Bidwell.
- RECRUITING
- Registry status
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of two different strains of cannabis flower one day and while not intoxicated another day. Event-related potentials (ERPs) are measured via electroencephalogram (EEG) during the recognition memory task. Blood is collected to quantify THC and CBD exposure. Participants also complete self-report measures of medical history, sleep quality, subjective cognitive function, physical activity, psychological functioning, substance use, and acute drug effects.
Primary Outcome
Electroencephalography is used to quantify FN400.
Conditions Studied
Interventions
- DRUG Cannabis (smoked flower)
Study Locations (1)
Colorado
- Center for Innovation and Creativity (CINC) - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2024-10-09 |
| Est. Completion | 2026-01 |
What NCT06669585 shows while recruiting
NCT06669585 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 108-participant average among 24 other Cannabis trials with a reported enrollment target (41% lower).
The record links to 3 conditions, with Cannabis appearing as the primary indexed condition, and to 1 intervention - of which Cannabis (smoked flower) is the first listed.
NCT06669585 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06669585 about?
NCT06669585 is a clinical study titled "Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 3". This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of two different strains of cannabis flower one day and while not in...
What is the current status of trial NCT06669585?
This trial is currently recruiting. The enrollment target is 64 participants. The study started on 2024-10-09. Estimated completion is 2026-01.
What conditions does trial NCT06669585 study?
This clinical trial studies the following conditions: Cannabis, Memory, Electroencephalography.
What interventions are being tested in trial NCT06669585?
The interventions under investigation include: Cannabis (smoked flower) (DRUG).
Who is sponsoring clinical trial NCT06669585?
This trial is sponsored by L. Cinnamon Bidwell, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06669585 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06669585's enrollment target sits among peer trials
64 11th of 24 higher than 14 of 24 other Cannabis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans
RECRUITING · Phase 1
-
Cannabis' Impact on Alcohol Consumption
RECRUITING · Phase 2
-
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
RECRUITING · Phase 2
-
Cannabis, HIV and Mental Processing Systems
RECRUITING
-
Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury
RECRUITING · NA
-
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI